SAN DIEGO, Nov. 12, 2010 /PRNewswire-FirstCall/ -- Gen-Probe
Incorporated (Nasdaq: GPRO) announced today that the Company will
webcast its annual briefing for institutional investors and
financial analysts at 1 p.m. Pacific
Time (PT) / 4 p.m. Eastern
Time (ET) on Thursday, December 16,
2010. The event, to be held at Gen-Probe headquarters
in San Diego, will feature
presentations by senior management on the Company's current
business and future growth strategies. The meeting and
webcast are expected to conclude at 4:30
p.m. PT / 7:30 p.m. ET.
The live webcast may be accessed on the investors section of the
Company's web site at www.gen-probe.com. An archived version
of the webcast also will be available for at least 30 days.
Institutional investors and financial analysts who wish to
attend the meeting in person should RSVP to
paula.izidoro@gen-probe.com.
About Gen-Probe
Gen-Probe Incorporated is a global leader in the development,
manufacture and marketing of rapid, accurate and cost-effective
molecular diagnostic products and services that are used primarily
to diagnose human diseases, screen donated human blood, and ensure
transplant compatibility. Gen-Probe has approximately 27
years of expertise in nucleic acid testing (NAT), and received the
2004 National Medal of Technology, America's highest honor for
technological innovation, for developing NAT assays for blood
screening. Gen-Probe is headquartered in San Diego and employs approximately 1,300
people. For more information, go to www.gen-probe.com.
Caution Regarding Forward-Looking Statements
Any statements in this press release about our expectations,
beliefs, plans, objectives, assumptions or future events or
performance are not historical facts and are forward-looking
statements. Forward-looking statements are not guarantees of
performance. They involve known and unknown risks, uncertainties
and assumptions that may cause actual results to differ materially
from those expressed or implied. For information about risks
and uncertainties we face and a discussion of our financial
statements and footnotes, see documents we have filed with the SEC,
including our most recent Form 10-K, and all subsequent periodic
filings. We assume no obligation and expressly disclaim any
duty to update any forward-looking statement to reflect events or
circumstances after the date of this press release or to reflect
the occurrence of unanticipated events.
Contact:
|
|
Paula Izidoro
|
|
Investor Relations
|
|
858-410-8904
|
|
|
SOURCE Gen-Probe Incorporated